TheStreet Network:
TheStreet
|
MainStreet
|
BankingMyWay
|
RealMoney
Home
About Stockpickr
|
How to Use
Portfolios
Professional
Warren Buffett
George Soros
T. Boone Pickens
Carl Icahn
» Most-Viewed
» Recently Updated
Stockpickr Spotlight
9 Oil Refining Stocks to Watch
Five Best-Performing Biotech Stocks of 2013
4 Turnarounds Poised for better days Ahead
Zombie Apocalypse Portfolio
5 Small-Cap Bank Stock Plays for 2013 From Credit Suisse
» More Spotlight Portfolios
User Generated
Recently Updated
Tools
Market Indicators
Top % Gainers
Top % Losers
52-Week Highs
52-Week Lows
Rising on Unusual Volume
Unusual Options Activity
Upgrades and Downgrades
Analyst Upgrades
Analyst Downgrades
TheStreet Ratings Upgrades
TheStreet Ratings Downgrades
Daily Lists
Cramer's "Lightning Round"
Insider Buying
Insider Selling
Earnings Announcements
Ex-Dividend Stocks
Dogs of the Dow
Articles
5 Stocks Under $10 Making Big Moves
3 Health Care Stocks Under $10 to Watch
5 Stocks Poised to Pop on Bullish Earnings
5 Buy Signals From the Consumer Sector
3 Stocks Rising on Unusual Volume
» More Articles
My Stockpickr
Log In
|
Join for Free
Stock Game
Health Care: Drugs
NABI Biopharmaceuticals Inc. (NABI: NASDAQ)
$10.80
0.00 | 0.00%
11/12/12 - 12:15 AM ET
Quote
Ratings
Earnings
Fundamentals
Options Chain
Advanced Chart
Balance Sheet
Cash Flow
Income Statement
Growth Rates
Major Holders
Ratio Comparison
0.00 / 178.80K
Vol / Avg. Vol:
10.80 / 10.80
Open / Prev. Close:
10.80 - 10.80
Today's Range:
1.77 - 12.18
52 Wk Range:
0.00%
Performance YTD:
No Rating
TheStreet Rating:
Find out if NABI is in Cramer's Portfolio
6-MONTH
CHART:
1-Day
|
5-Day
|
1-Month
|
3-Month
|
6-Month
|
1-Year
See Advanced Charting for NABI
Portfolios with
NABI
Portfolio Name
User Type
Contributor
Earnings Short Squeeze Play...
Contributor
Breakout Stocks Of The Week...
User
PRossmango - Speculative Lo...
Contributor
10 Biotech Stocks Expected ...
Contributor
Barron's Activist Stocks 5-...
Contributor
Barron's Activist Stocks 4-...
Contributor
Barron's Activist Stocks 4-...
User
wlpncp Portfolio 1
Contributor
Charts of the Week - 1-27-2009
Contributor
Barron's Insider Purchases ...
View All
Latest
NABI
Headlines from TheStreet
Nabi Biopharmaceuticals Announces Nabi Stockholder Meeting Results And The Approval Of The Business Combination Transaction By Biota Stockholders
10.23.12 | 05:10 pm
Nabi Biopharmaceuticals Announces Exchange Ratio For Proposed Business Combination Transaction With Biota Holdings Limited
10.19.12 | 07:10 am
Nabi Biopharmaceuticals Announces Results Of NicVAX(R) Phase II Study In Combination With Varenicline
10.17.12 | 07:10 am
Nabi Biopharmaceuticals Sets Record Date For Cash Dividend
10.16.12 | 04:10 pm
Two Major Independent Proxy Advisory Firms Recommend Nabi Biopharmaceutical Stockholders Support Amended Transaction With Biota Holdings Limited At October 22nd Reconvened Special Meeting
10.16.12 | 08:10 am
Nabi Biopharmaceuticals Announces Adjournment Of Special Meeting Of Stockholders Until October 22, 2012
09.24.12 | 03:09 pm
Nabi Biopharmaceuticals And Biota Holdings Limited Amend Terms Of Business Combination; Mangrove Partners Agrees To Support The Amended Transaction
09.17.12 | 05:09 pm
Biota In Advanced Discussions With Russell H. Plumb To Assume Role Of President And CEO Of Biota Pharmaceuticals, Inc.
09.06.12 | 04:09 pm
Nabi Sends Letter To Stockholders Responding To Mangrove's Statements And Calls On Stockholders To Vote Their White Proxy Card Today
08.23.12 | 06:08 am
Nabi Biopharmaceuticals Announces Second Quarter 2012 Financial Results
08.09.12 | 04:08 pm
More Financial News for NABI
Press Releases for
NABI
Mangrove Partners Agrees To Support Amended Transaction Between Nabi Biopharmaceuticals And Biota Holdings
- PR Newswire 09.19.12 | 09:09 pm
ISS And Glass Lewis Both Recommend That Stockholders Vote Against The Nabi/Biota Merger
- PR Newswire 09.12.12 | 08:09 pm
Mangrove Partners Sends Letter To Stockholders Of Nabi Biopharmaceuticals
- PR Newswire 08.16.12 | 09:08 am
See All Press Releases
Partner Headlines for
NABI
Mangrove Partners Sends Letter to Holders of Nabi Biopharma; Urges Vote Against Merger
- Benzinga 08.16.12 | 09:08 am
Company News for July 19, 2011 - Corporate Summary
- Zacks 07.19.11 | 10:07 am
Seth Hamot: Look for Bad Business Models, Too Much Leverage and Selfish Management
- Seeking Alpha 07.07.10 | 08:07 am
Dan Loeb's Hedge Fund Third Point Starts Multiple New Positions, Exits Citigroup
- Seeking Alpha 05.24.10 | 05:05 pm
Nabi Vaccine Program Advances - Analyst Blog
- Zacks 03.19.10 | 04:03 pm
Refresh Stock Quote for NABI Biopharmaceuticals Inc. - NABI
Go All-In On Actavi...
May CPI and Housing...
IPOs: Votorantim, Gogo
Home
About Stockpickr
How to Use
Join for FREE
STOCK GAME
Portfolios
Professional
Warren Buffett
George Soros
T. Boone Pickens
Carl Icahn
Most-Viewed
Recently Updated
Stockpickr Spotlight
9 Oil Refining Stocks to Watch
Five Best-Performing Biotech Stocks of 2013
4 Turnarounds Poised for better days Ahead
Zombie Apocalypse Portfolio
5 Small-Cap Bank Stock Plays for 2013 From Credit Suisse
More Spotlight Portfolios
User Generated
Recently Updated
Tools
Market Indicators
Top % Gainers
Top % Losers
52-Week Highs
52-Week Lows
Rising on Unusual Volume
Unusual Options Activity
Upgrades and Downgrades
Analyst Upgrades
Analyst Downgrades
TheStreet Ratings Upgrades
TheStreet Ratings Downgrades
Daily Lists
Cramer's "Lightning Round"
Insider Buying
Insider Selling
Earnings Announcements
Ex-Dividend Stocks
Dogs of the Dow
Articles
5 Stocks Under $10 Making Big Moves
3 Health Care Stocks Under $10 to Watch
5 Stocks Poised to Pop on Bullish Earnings
5 Buy Signals From the Consumer Sector
3 Stocks Rising on Unusual Volume
More Articles
My Stockpickr
My Stockpickr Profile
Inbox
Add New Portfolio
Edit My Profile